ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Parenteral Nutrition Market (2021 to 2027) - Featuring Baxter International, Grifols and Pfizer Among Others - ResearchAndMarkets.com

December 23, 2021 GMT

DUBLIN--(BUSINESS WIRE)--Dec 23, 2021--

The “Global Parenteral Nutrition Market By Nutrient Type (Single Dose Amino Acid Solution, Parenteral Lipid Emulsion, Carbohydrates, Trace Elements, and Vitamins & Minerals), By Regional Outlook, COVID-19 Impact Analysis Report and Forecast, 2021 - 2027” report has been added to ResearchAndMarkets.com’s offering.

The global parenteral nutrition market size is expected to reach $10.9 billion by 2027, rising at a market growth of 8.1% CAGR during the forecast period.

ADVERTISEMENT

Parenteral nutrition (parenteral nutrition), or intravenous feeding, provides liquid nutrients such as proteins, vitamins, fats, electrolytes, minerals, and carbohydrates. It is a component of specialized nutritional therapy that renders nutritional support to patients who are not able to use their gastrointestinal tract properly. It is extremely helpful in eliminating malnutrition and maintaining hydration, energy, and strength levels. Due to this, it is broadly utilized among patients who are suffering from cancer, hydration, Crohn’s disease, ischemic bowel disease, short bowel syndrome, and abnormal bowel function.

The development of the parenteral nutrition market is expected to be fueled by the surge in the occurrence of malnutrition among children, mainly in the emerging and under-developed nations around the globe. Additionally, the requirement for parenteral nutrition (parenteral nutrition) to appropriately balance amino acids, lipids, vitamins, minerals, and other nutrients is expected to create bright growth prospects for the growth of the parenteral nutrition market.

The adoption of parenteral nutrition is expected to fuel as it reduces the chances of underdevelopment and infection. Very-Low-Birth-Weight (VLBW) newborns are witnessing a huge demand for parenteral nutrition products due to the low possibility of Enteral Nutrition (EN). Additionally, a surge in the acceptance of parenteral nutrition for premature infants that results in better neurological growth enhanced intrauterine nutrient deposition, and lower chances of complications, hence enhancing their possibility of survival.

COVID-19 Impact Analysis

ADVERTISEMENT

The outbreak of the COVID-19 pandemic has substantially boosted the adoption rate of parenteral nutrition to offer the required nutrition and fluids needed by the body for rapid and safe recovery. In addition, the increasing acceptance of the administration of nutrition by the parenteral medium as compared to enteral feeding among the patients suffering from the COVID-19 for fulfilling the required nutritional needs, rising nutrient absorption, and declining infection risk is expected to accelerate the demand & growth of the overall parenteral nutrition market in the upcoming years.

Moreover, the rising adoption of these formulations among the clinicians for assisting the patients to fulfill their target nutrition consumption, enhance recovery, and cut down the hospital stays are some of the factors propelling the development of the global parenteral nutrition market.

Market Growth Factors:

The surge in the rate of malnutrition among the global population

In addition, the governments of numerous countries are undertaking various initiatives with an aim to cut down the growing burden of malnutrition, hence increased the intravenous feeding demand. Various government organizations such as Action against Hunger, Food4Africa, Heifer International, and World Health Organization are willing to take new initiatives that aim to offer better treatment for malnourished individuals.

Higher prevalence of different chronic diseases

Various kinds of diseases like head & neck cancer, esophageal cancer, Crohn’s, ulcerative colitis, gastric cancer, and laryngeal cancer can have an impact on oral food consumption among the patients. Due to their increasing occurrence, the global parenteral nutrition market is expected to be propelled in the upcoming years.

Market Restraining Factor:

Increasing inclination toward enteral nutrition

The preference toward enteral nutrition is constantly increasing among patients across the globe. Medical specialists generally suggest the use of enteral feeding in comparison to parenteral feeding. This is due to the fact that it is less expensive, can be easily administered, and have fewer complications. Moreover, enteral feeding enables better and effective nutrient consumption and supports the natural healing process of the body through the stimulation of the intestinal blood flow.

Market Segments Covered in the Report:

By Nutrient Type

  • Single Dose Amino Acid Solution
  • Parenteral Lipid Emulsion
  • Carbohydrates
  • Trace Elements,
  • Vitamins & Minerals

By Geography

  • North America
  • US
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players:

  • Vifor Pharma Management Ltd.
  • Baxter International, Inc.
  • Allergan PLC (AbbVie)
  • B.Braun Melsungen AG
  • Fresenius SE & Co. KGaA
  • Grifols S.A.
  • Pfizer, Inc.
  • ICU Medical, Inc.
  • Anhui Medipharm Co., Ltd.
  • Aculife Healthcare Private Limited

For more information about this report visit https://www.researchandmarkets.com/r/5dvg30

View source version on businesswire.com:https://www.businesswire.com/news/home/20211223005267/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH OTHER HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2021.

PUB: 12/23/2021 08:08 AM/DISC: 12/23/2021 08:08 AM

http://www.businesswire.com/news/home/20211223005267/en